Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Randomized Phase III Trial of Six Cycles of Docetaxel Versus Surveillance After Radical Prostatectomy in High Grade Prostate Cancer Patients With Margin Positive T2 or T3 Tumours

NCT00376792 is registered in ClinicalTrials.gov with Scandinavian Prostate Cancer Group as lead sponsor.

NCT NCT00376792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00376792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Randomized Phase III Trial of Six Cycles of Docetaxel Versus Surveillance After Radical Prostatectomy in High Grade Prostate Cancer Patients With Margin Positive T2 or T3 Tumours
Lead sponsor
Scandinavian Prostate Cancer Group
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2005
Completion date
Not reported
Enrollment
396 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer